Drug
Sutantatug Envedotin clinical trials
Also written SYS6002.
Keep track of what changes. Save the Sutantatug Envedotin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
CSPC Megalith Biopharmaceutical Co.,Ltd. (4) · Corbus Pharmaceuticals Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Sutantatug Envedotin is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell CarcinomaRecruitingPhase 3Corbus Pharmaceuticals Inc.NCT07768189Written as CRB-701
- SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial CarcinomaNot yet recruitingPhase 3CSPC Megalith Biopharmaceutical Co.,Ltd.NCT07526792Written as SYS6002
- SYS6002 vs PADCEV in Patients With Advanced Urothelial CarcinomaNot yet recruitingPhase 2CSPC Megalith Biopharmaceutical Co.,Ltd.NCT07374549Written as SYS6002
- SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical CancerNot yet recruitingPhase 3CSPC Megalith Biopharmaceutical Co.,Ltd.NCT07230626Written as SYS6002
- SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCCNot yet recruitingPhase 2CSPC Megalith Biopharmaceutical Co.,Ltd.NCT06989671Written as SYS6002
Given in every arm · 2 — Sutantatug Envedotin is usual care beside what is tested
- A Phase 1/2 Study to Investigate CRB-701 in Solid TumorsRecruitingPhase 1/2Corbus Pharmaceuticals Inc.NCT06265727Written as CRB-701
- A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid TumorsRecruitingPhase 1/2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT07241936Written as SYS6002